合并脑出血的抗磷脂综合征治疗体会:附病例报告  

Clinical Treatment Experiences on Antiphospholipid Syndrome Patient Combined with Cerebral Hemorrhage:Case Report Attached

作　　者：吴莹[1] 林昌松[2] 刘风震[1] 徐强[2] 毛海琴[3] 

机构地区：[1]广州中医药大学第一临床医学院,广东省广州市510006 [2]广州中医药大学第一附属医院 [3]云南中医学院第一附属医院

出　　处：《中国全科医学》2014年第15期1756-1758,共3页Chinese General Practice

摘　　要：本文通过对本院2013-05-30收治的1例合并脑出血的全身多发动静脉栓塞的抗磷脂综合征(APS)患者进行回顾性分析,探讨APS的诊疗,以加强临床医生对本病的认识。提示:对不明原因血管内血栓形成的患者,应行风湿免疫学检测;恶性抗磷脂综合征(CAPS)因其预后极差,一旦怀疑应积极治疗;伴有出血风险的APS患者,需根据医生个人经验,结合临床实际,充分做好出血风险评估,权衡利弊,谨慎处理。One antiphospholipid syndrome（APS） patient combined with general multiple arterial and venous embolism and cerebral hemorrhage was admitted to our hospital on 30 May 2013,the clinical data of this case was analyzed retrospectively in this article,and the diagnosis and treatment of APS were discussed,so as to improve the understanding of clinical doctors for APS.Note：rheumatism immunology test should be carried out among the patients with unexplained thrombosis in blood vessels.Because the prognosis of catastrophic antiphospholipid syndrome（CAPS） is poor,once CAPS is suspected,active therapy strategies should be taken.According to experiences of doctors and clinical practice,APS patients with the risk of bleeding should receive risk assessment,doctors should weight the advantages and disadvantages,and treat carefully.

关 键 词：脑出血 血栓栓塞 抗磷脂综合征 

分 类 号：R593.2[医药卫生—内科学]